AMA Ed Hub Logo

Learn more on prescription drugs from AMA Ed Hub™
Red JAMA Logo

Learn more on prescription drugs from JAMA Network™
2025 Annual Meeting of the HOD

Learn more on prescription drugs from PolicyFinder
United States Adopted Names Council

United States Adopted Names (USAN)
Clear Search
·
2 Min Read

Medicare financial data going public: Review yours now

Physicians have until May 15 to review and dispute reports about financial interactions with manufacturers of drugs and medical devices reported under the the Open Payments program.

Medicare & Medicaid
National Advocacy Conference panel
·
5 Min Read

Experts explain high drug prices, offer solutions

Addressing the rising cost of prescription drugs, 3 experts in the pharmaceuticals field discuss marketplace trends affecting drug spending and pricing. They also discuss solutions to address drug prices and availability.

Behavioral Health
·
2 Min Read

AMA overview clarifies CME reporting under the Sunshine Act

The AMA has provided an overview that addresses concerns about reporting requirements and participation in commercially supported, accredited and certified continuing medical education (CME) programs in 2016.

Behavioral Health
·
3 Min Read

From Rx prices to EHRs: Top stories from the 2015 AMA Interim Meeting

The 2015 AMA Interim Meeting took place this week. Read these highlights from the meeting, and see AMA Wire's® full coverage of the event to learn more.

Interim Meeting
·
4 Min Read

Physicians call for fairness in drug prices, availability

In response to increasing drug costs impacting patient access to needed medications, physicians voted Monday at the 2015 Interim Meeting to convene a task force and launch an advocacy campaign to drive solutions and help make prescription drugs more affordable. Physicians also are calling for greater competition in the pharmaceutical industry and transparency in prescription drug prices and costs.

Behavioral Health
·
5 Min Read

CDC panel shares solutions to combat antibiotic resistance

The Centers for Disease Control and Prevention (CDC) estimates that 2 million U.S. illnesses and 23,000 deaths each year are caused by antibiotic-resistant infections, and these result in an estimated $20 billion in excess health care costs.

Behavioral Health
·
3 Min Read

AMA calls for ban on DTC ads of prescription drugs and medical devices

Physicians at the AMA Interim Meeting adopted new policy aimed at driving solutions to make prescription drugs more affordable.

Press Releases
·
3 Min Read

AMA continues efforts to combat antibiotic resistance

The AMA today adopted policy during its Interim Meeting to help combat the spread of antibiotic resistant bacteria in all health care facilities.

Press Releases
·
3 Min Read

3 answers to know about Sunshine Act data going public

The second release of physicians’ financial data under the Physician Payments Sunshine Act, also known as the Open Payments program, was June 30. Learn the answers to three questions patients or others may ask you about your 2014 financial data.

Medicare & Medicaid